These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34917417)
1. The SP/NK1R System-Mediated ROS Generation in GBM Cells through Inhibiting Glutaredoxin Protein. Mehrabani N; Vaezi Kakhki MR; Javid H; Ebrahimi S; Hashemy SI Neurol Res Int; 2021; 2021():9966000. PubMed ID: 34917417 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of the SP/ NK1R system in GBM cells through inhibiting the thioredoxin system. Ghahremani F; Sabbaghzadeh R; Ebrahimi S; Javid H; Ghahremani J; Hashemy SI Iran J Basic Med Sci; 2021 Apr; 24(4):499-505. PubMed ID: 34094032 [TBL] [Abstract][Full Text] [Related]
3. The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells. Zarei Shandiz S; Assaran Darban R; Javid H; Ghahremanloo A; Hashemy SI Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5875-5882. PubMed ID: 38334824 [TBL] [Abstract][Full Text] [Related]
4. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses. Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877 [TBL] [Abstract][Full Text] [Related]
5. The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells. Korfi F; Javid H; Assaran Darban R; Hashemy SI Biochem Res Int; 2021; 2021():6620708. PubMed ID: 33976938 [TBL] [Abstract][Full Text] [Related]
6. The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification. Rezaei S; Assaran Darban R; Javid H; Hashemy SI Biomed Res Int; 2022; 2022():8540403. PubMed ID: 35281606 [TBL] [Abstract][Full Text] [Related]
7. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer. Mozafari M; Ebrahimi S; Darban RA; Hashemy SI Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230 [TBL] [Abstract][Full Text] [Related]
8. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant. Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells. AlAlikhan A; Ghahremanloo A; Javid H; Ebrahimi S; Hashemy SI Cell Biochem Biophys; 2022 Dec; 80(4):819-827. PubMed ID: 36197642 [TBL] [Abstract][Full Text] [Related]
10. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605 [TBL] [Abstract][Full Text] [Related]
11. The redox modulatory effects of SP/NK1R system: Implications for oxidative stress-associated disorders. Ebrahimi S; Alalikhan A; Aghaee-Bakhtiari SH; Hashemy SI Life Sci; 2022 May; 296():120448. PubMed ID: 35247438 [TBL] [Abstract][Full Text] [Related]
12. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy. Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486 [TBL] [Abstract][Full Text] [Related]
13. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells. Golestaneh M; Firoozrai M; Javid H; Hashemy SI Mol Biol Rep; 2022 Jun; 49(6):4893-4900. PubMed ID: 35429316 [TBL] [Abstract][Full Text] [Related]
14. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice. Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954 [TBL] [Abstract][Full Text] [Related]
15. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R). Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883 [TBL] [Abstract][Full Text] [Related]
16. Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. Manak MM; Moshkoff DA; Nguyen LT; Meshki J; Tebas P; Tuluc F; Douglas SD AIDS; 2010 Nov; 24(18):2789-96. PubMed ID: 20975512 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells. Han JM; Kim YJ; Jung HJ Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267623 [TBL] [Abstract][Full Text] [Related]
18. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells. Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203 [TBL] [Abstract][Full Text] [Related]
19. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis. Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298 [TBL] [Abstract][Full Text] [Related]
20. Substance P enhances the local activation of NK Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]